EMBC
Embecta Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.25
−4.73%Forward multiples
Based on analyst estimates
- P/E forward
- 3.46x
- P/E 2026E
- 3.48x
- P/E 2027E
- 3.62x
- P/E 2028E
- 3.27x
- P/S forward
- 0.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.19x
- PEG TTM
- 0.20x
- Price / book
- -0.58x
- Price / sales
- 0.35x
- Price / cash flow
- 2.03x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 1.61x
- EV / EBITDA
- 6.17x
- EV / EBIT
- 6.48x
- Market cap
- $354.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026